scispace - formally typeset
D

Dean D. Erdman

Researcher at Centers for Disease Control and Prevention

Publications -  208
Citations -  26613

Dean D. Erdman is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Respiratory tract infections & Human metapneumovirus. The author has an hindex of 72, co-authored 208 publications receiving 24423 citations. Previous affiliations of Dean D. Erdman include National Center for Immunization and Respiratory Diseases & University of Georgia.

Papers
More filters
Journal Article

Acute hemorrhagic conjunctivitis outbreaks caused by coxsackievirus A24v - Uganda and Southern Sudan, 2010.

TL;DR: Widespread, ongoing outbreaks of acute hemorrhagic conjunctivitis have been observed in Uganda and Southern Sudan since spring 2010, and case numbers were estimated after MoH confirmation of reported cases from district health facilities and, in Southern Sudan, after a medical record review in six health facilities.
Journal ArticleDOI

Laboratory Investigation and Phylogenetic Analysis of an Imported Middle East Respiratory Syndrome Coronavirus Case in Greece

TL;DR: Initial inconclusive rRT-PCR results highlight the importance of collecting multiple specimens from suspect MERS-CoV cases and particularly specimens from the lower respiratory tract, and identified a unique amino acid substitution in the spike receptor binding domain that may have implications for receptor binding efficiency.
Patent

Coronavirus isolated from humans

TL;DR: In this article, a newly isolated human coronavirus (SARS-CoV), the causative agent of severe acute respiratory syndrome, was described and its nucleic acid sequence and amino acid sequences of the open reading frames were provided.
Journal ArticleDOI

Unraveling the Mysteries of Middle East Respiratory Syndrome Coronavirus

TL;DR: Standard, contact, and airborne precautions appear to be effective in limiting transmission and are recommended by the Centers for Disease Control and Prevention to manage known or suspected MERS-CoV infection in hospitalized patients as a primary means of preventing and controlling transmission.